Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates
桥接抗体 Fc 介导的人类和非人类灵长类动物的抗病毒功能
基本信息
- 批准号:9925737
- 负责人:
- 金额:$ 410.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsAntibodiesAntigen-Antibody ComplexAntiviral AgentsBiologyBiophysicsCellsChemicalsClinicClinical TrialsCollaborationsCommunicationEffector CellEnsureEpitopesExpression ProfilingFc ReceptorFc domainFinancial ActivityGenotypeGoalsGrantHIVHIV vaccineHIV-1HIV-1 vaccineHumanHuman immunodeficiency virus testImmune systemImmunityInfection preventionInstitutesInstitutionInterventionLearningMacaca mulattaMapsMediatingMemoryModelingMonitorMonoclonal AntibodiesOutcomePassive ImmunizationPhenotypePositioning AttributePrevention strategyRecording of previous eventsRegimenResearch PersonnelResourcesRhesusRiskRoleSpecificityStructureSupervisionTestingTranslatingTranslationsVaccine DesignVaccinesVirionVirusWorkantigen bindingbasedesignefficacy trialexperienceglycosylationimmunoprophylaxisimprovedinsightnonhuman primateprogramspublic health relevancereceptor functionrecruitresponsesuccesssynergismtooltranslation to humansvaccine developmentvaccine trial
项目摘要
DESCRIPTION (provided by applicant): HIV-1 vaccine efficacy trials and multiple animal studies, including those related to HIV-cure strategies, have shown that antibody interactions with cells - mediated by the antibody constant (Fc) region - can harness multiple aspects of the immune system to provide protection through mechanisms other than by neutralization. However, it is unknown whether candidate HIV-1 vaccine regimens that include induction of Fc-mediated antibody functions can be tested in the rhesus macaque (RM) nonhuman primate (NHP) in a way that can be translated to humans. In order to more effectively translate insights gained from RM studies to the clinic, there is a need to fully define the protective signatures of Fc-mediated antibody functions across rhesus macaques and humans. The work we propose will map antibody (Ab) and Fc-receptor (FcR) biology across humans and RMs with the goal of making observed protective responses in RMs more predictive of human responses, thus accelerating the most promising vaccine concepts to be advanced to the clinic with success. Our central hypothesis is that the RM model can be substantially improved for testing antibody-based interventions and vaccines through elucidation of key variables that impact species-specific FcγR-dependent effector functions (i.e. antibody epitope specificity, immune complex formation, isotype/subclass, glycosylation, and FcR genotype/phenotype). To test this, we propose three synergistic, inter-related scientific Projects supported by three Cores to achieve the following Overall Aims: Overall AIM 1. Characterize effective anti-HIV-1 Fc-FcR biology across RM to humans. Overall AIM 2. Define HIV-1 virion and infected cell epitopes for antibody recognition. Overall AIM 3. Determine the Fv and Fc features of antibodies yielding maximal anti-HIV-1 activity.
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Coming together at the hinges: Therapeutic prospects of IgG3.
- DOI:10.1080/19420862.2021.1882028
- 发表时间:2021-01
- 期刊:
- 影响因子:5.3
- 作者:Chu TH;Patz EF Jr;Ackerman ME
- 通讯作者:Ackerman ME
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge.
- DOI:10.1371/journal.ppat.1008764
- 发表时间:2020-09
- 期刊:
- 影响因子:6.7
- 作者:Om K;Paquin-Proulx D;Montero M;Peachman K;Shen X;Wieczorek L;Beck Z;Weiner JA;Kim D;Li Y;Mdluli T;Shubin Z;Bryant C;Sharma V;Tokarev A;Dawson P;White Y;Appelbe O;Klatt NR;Tovanabutra S;Estes JD;Matyas GR;Ferrari G;Alving CR;Tomaras GD;Ackerman ME;Michael NL;Robb ML;Polonis V;Rolland M;Eller MA;Rao M;Bolton DL
- 通讯作者:Bolton DL
Recent insights into Fc-mediated effector responses to HIV-1.
- DOI:10.1097/coh.0000000000000638
- 发表时间:2020-09
- 期刊:
- 影响因子:4.1
- 作者:Carpenter MC;Ackerman ME
- 通讯作者:Ackerman ME
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGIA Doris TOMARAS其他文献
GEORGIA Doris TOMARAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGIA Doris TOMARAS', 18)}}的其他基金
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
- 批准号:
10258146 - 财政年份:2021
- 资助金额:
$ 410.48万 - 项目类别:
Mechanisms of Antibody Fc Mediated Protection
抗体 Fc 介导的保护机制
- 批准号:
10475284 - 财政年份:2021
- 资助金额:
$ 410.48万 - 项目类别:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
- 批准号:
10670229 - 财政年份:2021
- 资助金额:
$ 410.48万 - 项目类别:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
- 批准号:
10475274 - 财政年份:2021
- 资助金额:
$ 410.48万 - 项目类别:
Mechanisms of Antibody Fc Mediated Protection
抗体 Fc 介导的保护机制
- 批准号:
10258150 - 财政年份:2021
- 资助金额:
$ 410.48万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 410.48万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 410.48万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 410.48万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 410.48万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 410.48万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 410.48万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 410.48万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 410.48万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 410.48万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 410.48万 - 项目类别:
Training Grant